A Study of Flurpiridaz (18F) Injection for PET Imaging for Assessment of MPI Quality Using HPLC and SPE Manufacturing Processes

NCT04594941 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease (CAD)
Ischemic Heart Disease

Interventions

DRUG: Flurpiridaz (18F) Injection

Sponsor

GE Healthcare